Quarterly Result30 Oct 2025, 01:07 pm
Cipla Ltd Reports Q2 and H1 Results for FY2025-26 with 11% YoY Revenue Growth
AI Summary
Cipla Ltd, a leading global pharmaceutical company, has reported its financial results for the quarter and half year ended 30th September, 2025. The company recorded a standalone revenue from operations of INR 3,747.42 crores and INR 7,447.42 crores for the quarter and half year respectively, representing an 11% YoY growth. The net profit after tax stood at INR 1,314.80 crores for the half year. The company's pharmaceuticals segment contributed INR 6,579.42 crores and INR 13,870.85 crores to the total revenue for the quarter and half year respectively.
Key Highlights
- Revenue from operations for H1 FY2025-26 stood at INR 7,447.42 crores, representing an 11% YoY growth.
- Net profit after tax for H1 FY2025-26 was INR 1,314.80 crores.
- Pharmaceuticals segment contributed INR 13,870.85 crores to the total revenue for H1 FY2025-26.
- The company has voluntarily deposited INR 27.07 crores with the NPPA against certain demand notices.
- Cipla expects a favourable outcome in the ongoing litigation related to demand notices and hence no provision is considered necessary.